España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
VanEck Pharmaceutical ETF
PPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$86.27
0.96
1.13%
At close: -
$87.78
1.51
1.75%
After Hours: 4:20 PM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for VanEck Pharmaceutical ETF (NASDAQ:PPH)
VanEck Pharmaceutical ETF (NASDAQ: PPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, August 14, 2024
Pharma ETFs in Focus Post Solid Q2 Earnings
Zacks
Wednesday, June 12, 2024
Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
Shivani Kumaresan
Thursday, May 09, 2024
A Look at Pharma ETFs Post Q1 Earnings
Zacks
Friday, March 08, 2024
Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
Piero Cingari
Wednesday, February 28, 2024
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
Stjepan Kalinic
Tuesday, October 03, 2023
Biden-Harris Administration Moves Forward wit...
Charles Gross
Tuesday, November 24, 2020
Write A Prescription For This Pharma ETF
ETF Professor
Monday, August 31, 2020
A Divergence Has Occurred In Healthcare
Spencer Israel
Monday, September 09, 2019
10 ETFs That Could Be Primed For A Short Squeeze
Wayne Duggan
Thursday, November 09, 2017
Pharma ETFs Down Post Q3 Earnings
Benzinga
Monday, July 10, 2017
What Lies Ahead For Pharma ETFs In Second Half 2017
Benzinga
Tuesday, September 27, 2016
Getting Into The Drug Business: From NDAs To PDUFA Dates
Benzinga
Wednesday, August 24, 2016
Write A Prescription For More Pharma M&A With This ETF
Benzinga
Wednesday, April 06, 2016
PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure
Benzinga
Tuesday, March 15, 2016
New Study Suggests Drug Prices Have Doubled Since 2011: What's It Mean For The Market?
Benzinga
Thursday, January 14, 2016
New ETF Is A Refined Pharmaceuticals Play
Benzinga
Saturday, January 02, 2016
UPDATE: Speaking On Pharma Patents Kyle Bass Says 'there are some stupid patents out there', Highlights Intellectual Patent On Vile Protecting Diprivan Drug
Benzinga
Wednesday, September 30, 2015
This ETF Has A Valeant Problem
Benzinga
Tuesday, July 28, 2015
ETFs For The Next Pharma Takeover Candidates
Benzinga
Wednesday, October 22, 2014
Drug ETFs Attractive Buys On Pullback
Benzinga
Tuesday, July 29, 2014
Pharmaceutical ETFs Are Health Care Sector Standouts
Benzinga
Friday, April 25, 2014
3 Ways To Profit From Merger Activity In The Pharmaceutical Sector
Benzinga
Tuesday, April 22, 2014
Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)
Benzinga
Thursday, February 20, 2014
Pharma ETFs On The Move Again (IHE, PJP, PPH, ACT, FRX)
Benzinga
Wednesday, May 01, 2013
Earnings Trigger Volume Spike in Pharma ETF
Benzinga
Thursday, April 25, 2013
ETFs to Watch April 25, 2013 (FLOT, GDX, XLE)
Benzinga
Thursday, April 11, 2013
ETF Showdown: A Pharma Fight
Benzinga
Thursday, February 28, 2013
If The Market Falls, Try These Low Beta ETFs
Benzinga
Monday, January 07, 2013
4 Health Care ETFs Your Broker Forgot to Mention
Benzinga
Wednesday, November 07, 2012
More Pain Awaits Medical Device ETFs
Benzinga
Thursday, November 01, 2012
These ETFs Could Soar in November
Benzinga
Thursday, August 02, 2012
ETFs to Watch August 2, 2012 (BAB, FXC, NUGT)
Benzinga
Friday, July 20, 2012
ETFs to Watch July 20, 2012 (EWZ, FXE, PCY)
Benzinga
Wednesday, June 13, 2012
ETFs to Watch June 14, 2012 (EUO, EPV, XRT)
Benzinga
Wednesday, June 06, 2012
An Interesting ETF Option for the Generic Drug Boom (RTH, XLV)
Benzinga
Thursday, April 19, 2012
S&P: Bullish On Pharma ETFs Long-Term
Benzinga
Monday, April 02, 2012
Loving Low-Beta ETFs (XLP, XLV, VTV)
Benzinga
Sunday, April 01, 2012
ETFs to Watch April 2, 2012 (XLK, IAU, YCS)
Benzinga
Friday, March 30, 2012
ETFs to Watch March 30, 2012 (SEA, JNK, PPH)
Benzinga
Wednesday, March 28, 2012
ETFs to Watch March 28, 2012 (VXX, XHB, EDZ)
Benzinga
Friday, March 09, 2012
ETFs to Watch March 9, 2012 (GLD, IWM, SMH)
Benzinga
Monday, February 20, 2012
10 ETFs That Should Lower Their Expense Ratios
Benzinga
Friday, February 10, 2012
Grandpa's 2012 ETF Portfolio
Benzinga
Friday, January 27, 2012
Five Market Vectors ETFs to Split
Benzinga
Wednesday, January 04, 2012
Bark At The Dow's Dogs With These ETFs
Benzinga
Friday, December 30, 2011
ETF Showdown: Fun With Pharma
Benzinga
Tuesday, December 20, 2011
Van Eck Announces Results Of HOLDRs Exchange
Benzinga
6 HOLDRs Funds to Take Market Vectors Name On Tuesday
Benzinga
Sunday, November 13, 2011
Van Eck Begins Exchange Offers For Six HOLDRs Funds
Benzinga
Saturday, November 05, 2011
ETF Stats for October 2011: YTD Launches At 275
Benzinga
Show More
